423307000: Sitagliptin (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\Hydrolase inhibitor\Peptide hydrolase inhibitor\Dipeptidyl peptidase IV inhibitor\Sitagliptin (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Azole\Substance with triazole structure (substance)\Sitagliptin (substance)

\Organic compound\Organic cyclic compound\Heterocyclic compound\Azole\Substance with triazole structure (substance)\Sitagliptin (substance)
\Organic compound\Organic nitrogen compound\Azole\Substance with triazole structure (substance)\Sitagliptin (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2007. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Sitagliptin (substance)	Is a	Triazole derivative	false	Inferred relationship	Some
Sitagliptin (substance)	Is a	Dipeptidyl peptidase IV inhibitor	true	Inferred relationship	Some
Sitagliptin (substance)	Is a	Oral hypoglycemic	false	Inferred relationship	Some
Sitagliptin (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Dipeptidyl peptidase IV inhibitor (disposition)	true	Inferred relationship	Some
Sitagliptin (substance)	Is a	produit chimique catégorisé selon sa fonction	false	Inferred relationship	Some
Sitagliptin (substance)	Is a	Enzyme inhibitor	false	Inferred relationship	Some
Sitagliptin (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Serine proteinase inhibitor (disposition)	false	Inferred relationship	Some
Sitagliptin (substance)	Is a	Serine proteinase inhibitor	false	Inferred relationship	Some
Sitagliptin (substance)	Is a	Substance with triazole structure (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing sitagliptin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Sitagliptin (substance)	Inferred relationship	Some	1
Sitagliptin (as sitagliptin phosphate) 25 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Sitagliptin (substance)	Inferred relationship	Some
Product containing precisely sitagliptin (as sitagliptin phosphate) 50 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Sitagliptin (substance)	Inferred relationship	Some
Sitagliptin (as sitagliptin phosphate) 100 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Sitagliptin (substance)	Inferred relationship	Some
Sitagliptin phosphate (substance)	Is a	False	Sitagliptin (substance)	Inferred relationship	Some
Product containing metformin and sitagliptin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Sitagliptin (substance)	Inferred relationship	Some	2
Sitagliptin (as sitagliptin phosphate) 25 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Sitagliptin (substance)	Inferred relationship	Some	1
Sitagliptin (as sitagliptin phosphate) 100 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Sitagliptin (substance)	Inferred relationship	Some	1
Product containing precisely sitagliptin (as sitagliptin phosphate) 50 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Sitagliptin (substance)	Inferred relationship	Some	1
Sitagliptin phosphate (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Sitagliptin (substance)	Inferred relationship	Some
Product containing metformin and sitagliptin in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Sitagliptin (substance)	Inferred relationship	Some	2
Product containing sitagliptin in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Sitagliptin (substance)	Inferred relationship	Some	1
Product containing only metformin and sitagliptin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Sitagliptin (substance)	Inferred relationship	Some	2
Product containing only sitagliptin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Sitagliptin (substance)	Inferred relationship	Some	1
Sitagliptin only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Sitagliptin (substance)	Inferred relationship	Some	1
Product containing only metformin and sitagliptin in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Sitagliptin (substance)	Inferred relationship	Some	2
Metformin hydrochloride 500 mg and sitagliptin (as sitagliptin phosphate) 50 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Sitagliptin (substance)	Inferred relationship	Some	2
Product containing precisely metformin hydrochloride 850 milligram and sitagliptin (as sitagliptin phosphate) 50 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Sitagliptin (substance)	Inferred relationship	Some	2
Product containing precisely metformin hydrochloride 1 gram and sitagliptin (as sitagliptin phosphate) 50 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Sitagliptin (substance)	Inferred relationship	Some	2
Sitagliptin hydrochloride	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Sitagliptin (substance)	Inferred relationship	Some
Product containing precisely ertugliflozin (as ertugliflozin pidolate) 5 milligram and sitagliptin (as sitagliptin phosphate) 100 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Sitagliptin (substance)	Inferred relationship	Some	1
Product containing precisely ertugliflozin (as ertugliflozin pidolate) 15 milligram and sitagliptin (as sitagliptin phosphate) 100 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Sitagliptin (substance)	Inferred relationship	Some	1
Product containing only ertugliflozin and sitagliptin in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Sitagliptin (substance)	Inferred relationship	Some	1
Ertugliflozin- and sitagliptin-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Sitagliptin (substance)	Inferred relationship	Some	1
Ertugliflozin- and sitagliptin-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Sitagliptin (substance)	Inferred relationship	Some	1
Product containing only ertugliflozin and sitagliptin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Sitagliptin (substance)	Inferred relationship	Some	1
Product containing precisely metformin hydrochloride 1 gram and sitagliptin (as sitagliptin hydrochloride) 50 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Sitagliptin (substance)	Inferred relationship	Some	2
Product containing precisely metformin hydrochloride 850 milligram and sitagliptin (as sitagliptin hydrochloride) 50 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Sitagliptin (substance)	Inferred relationship	Some	2
Product containing precisely sitagliptin (as sitagliptin hydrochloride) 25 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Sitagliptin (substance)	Inferred relationship	Some	1
Sitagliptin (as sitagliptin hydrochloride) 50 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Sitagliptin (substance)	Inferred relationship	Some	1
Product containing precisely sitagliptin (as sitagliptin hydrochloride) 100 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Sitagliptin (substance)	Inferred relationship	Some	1
Sitagliptin malate	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Sitagliptin (substance)	Inferred relationship	Some
Sitagliptin fumarate (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Sitagliptin (substance)	Inferred relationship	Some

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
2640103016	Sitagliptin (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2644148012	Sitagliptin	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
54591000195116	sitagliptin	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
862821000172113	sitagliptine	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
68961000195115	Sitagliptin	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module